Jonathan Licht

Jonathan D. Licht, MD, is the Director of the University of Florida Health Cancer Center, leading it to become the 72nd NCI-designated center in the country. Dr. Licht’s laboratory studies the role of abnormal function of histone methyltransferases and demethylases in malignancies such as multiple myeloma and acute lymphoblastic leukemia and recently described a new class of mutations in histones in cancer. NCI funded for nearly 35 years, Dr. Licht is also Principal Investigator of a Leukemia and Lymphoma Society (LLS) Specialized Center of Research, now in its 17th year of funding. He is the founding Editor- in-Chief of Blood Neoplasia, a new journal of the American Society of Hematology, and serves on the editorial boards of Cancer Research, Oncogene and Clinical Cancer Research. Dr. Licht was the first chair of the AACR Taskforce on Hematological Malignancies of and currently is Chair of the Medical/Scientific Board of the LLS. Dr. Licht has published more than 230 articles, reviews and book chapters and has mentored over 40 graduate students and postdoctoral fellows and 20 faculty members.